deepc, a radiology AI startup founded in 2019, has successfully raised an additional $13 million in its Series A funding round, increasing the company’s total funding to date to $30 million. The company’s deepcOS platform helps radiology AI providers deploy their technologies in clinical settings through a single integration solution, offering access to regulatory-approved AI for over 60 clinical indications. This development aims to streamline AI adoption in healthcare, simplifying technical, operational, and commercial complexities for healthcare providers.
Strategic Partnerships and Investment
The company’s growth has been supported by notable investors including Sofinnova Partners and Bertelsmann Investments, with new participants like KHP Ventures and SwissHealth Ventures, in addition to existing investor Winning Mindset Ventures. Simon Turner, Partner at Sofinnova Partners, commented,
“The influx of capital into AI is highlighting the importance of enabling technologies that drive adoption in healthcare. These enabling technologies are the focus of the Sofinnova Digital Medicine strategy, and an area that few have yet to command. From the outset, we recognized deepc’s potential to revolutionize AI deployment in healthcare.”
Global Expansion and Future Plans
deepc’s platform is utilized by leading organizations such as Solothurn Hospital in Switzerland, the Vivantes Hospital Group and LMU University Hospital in Germany, CHU Brugmann in Belgium, and the NHS in England. Dr. Franz Pfister, CEO and Co-Founder of deepc, highlighted their mission,
“At deepc, we believe that the potential for AI in healthcare will only be realized if we can bridge the gap between cutting-edge AI and clinical practice. Our platform makes it easy for organizations to adopt the best AI technologies at pace and at scale, enabling faster, more accurate diagnoses and ultimately improving patient outcomes.”
The additional funds will facilitate deepc’s growth and international expansion, with a focus on extending its presence in North America, further expanding in the UK, and strengthening its foothold in key European markets. These efforts aim to enhance and commercialize its industry-leading operating system, deepcOS.
Historically, deepc has had a steady progression in securing partnerships and funding, reflecting the growing interest in AI technologies within the healthcare sector. Previous funding rounds have enabled the company to build a robust platform that now supports numerous healthcare institutions across multiple countries. This recent funding round reaffirms investor confidence in deepc’s ability to innovate and expand its market presence effectively.
Comparatively, the current funding landscape shows an increased emphasis on technologies that facilitate the integration of AI into clinical settings. deepc’s approach, focusing on broad access and user-friendly integration, positions it distinctly in a competitive market where ease of deployment is crucial for adoption.
As AI continues to be a transformative force in healthcare, companies like deepc are pivotal in ensuring its seamless integration into clinical practice. deepcOS simplifies the adoption of AI technologies by offering regulatory-approved solutions for numerous clinical indications, which can lead to faster and more accurate diagnoses. The funding acquired will aid in furthering these advancements and supporting global expansion, solidifying deepc’s role in the AI healthcare ecosystem. For healthcare providers, the accessibility to cutting-edge AI tools through deepc’s platform represents a significant step towards enhancing patient outcomes and operational efficiency.
